Interdisciplinary dream team receives $3 million grant to revolutionize Alzheimer’s diagnosis

What do a synthetic chemist, a medical imaging expert, and a neurologist have in common? They’re coming together in the Biomedical Imaging Center at the Beckman Institute for Advanced Science and Technology to develop better diagnostic tools and imaging agents to detect early-stage Alzheimer’s disease and other neurodegenerative diseases.

Interdisciplinary team reveals how Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy

A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer

June 18, 2024

It’s time to nominate your favorite private biotech for this year’s Endpoints 11

I’ve got a query for you today. Do you know a truly great private biotech out there with outstanding management, super science, ambitious and novel

June 18, 2024

OMERS snaps up drug royalties and milestones from Xencor for $215m – Pharmaceutical Technology

According to GlobalData’s Pharma Intelligence Centre, Ultomiris and Monjuvi have predicted sales of $3.65bn and $148m. Image credit: Shutterstock/JHVEPhoto. OMERS Life Sciences has acquired a

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.